Panagora Asset Management Inc Harpoon Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $124,130 - $350,074	-69,736 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$3.54 - $8.08 $54,243 - $123,809	-15,323 Reduced 18.01%	69,736 $347,000
Q4 2021 Feb 10, 2022	BUY	$5.69 - $7.83 $256,789 - $353,367	45,130 Added 113.03%	85,059 $642,000
Q3 2021 Nov 10, 2021	SELL	$7.88 - $14.0 $308,502 - $548,100	-39,150 Reduced 49.51%	39,929 $315,000
Q2 2021 Aug 11, 2021	SELL	$13.81 - $23.25 $78,275 - $131,781	-5,668 Reduced 6.69%	79,079 $1.1 Million
Q1 2021 May 12, 2021	BUY	$17.65 - $24.16 $346,328 - $474,067	19,622 Added 30.13%	84,747 $1.77 Million
Q4 2020 Feb 10, 2021	BUY	$12.83 - $17.84 $88,809 - $123,488	6,922 Added 11.89%	65,125 $1.08 Million
Q3 2020 Nov 13, 2020	BUY	$11.01 - $18.52 $579,390 - $974,596	52,624 Added 943.25%	58,203 $989,000
Q2 2020 Aug 12, 2020	BUY	$11.11 - $24.72 $61,982 - $137,912	5,579 New	5,579 $93,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.